Close Menu
  • Drugs
  • Diseases
  • Medical Tests
  • Health Topics
  • Quiz Center
  • Online Treatment Plan
  • Connect with a Doctor

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Anatomy 1

STEP 1

Toothache

Oral & Dental Health

Age-Related Cataracts

Eye Health
Facebook X (Twitter)
GoodMedTodayGoodMedToday
  • About Us
  • Support Us
Facebook X (Twitter)
SUBSCRIBE
  • Drugs
  • Diseases
  • Medical Tests
  • Health Topics
  • Quiz Center
  • Online Treatment Plan
  • Connect with a Doctor
GoodMedTodayGoodMedToday
Home - F - Fexofenadine
F

Fexofenadine

Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

Comprehensive Guide to Fexofenadine: Uses, Dosage, Side Effects, and More

Table of Contents

Toggle
  • What is Fexofenadine?
  • Overview of Fexofenadine
  • Indications and Uses of Fexofenadine
  • Dosage of Fexofenadine
  • How to Use Fexofenadine
  • Contraindications for Fexofenadine
  • Warnings & Precautions for Fexofenadine
  • Overdose and Management of Fexofenadine
  • Side Effects of Fexofenadine
  • Drug Interactions with Fexofenadine
  • Patient Education or Lifestyle
  • Pharmacokinetics
  • Pharmacodynamics of Fexofenadine
  • Storage
  • Frequently Asked Questions (FAQs)
  • Regulatory Information for Fexofenadine
  • References

What is Fexofenadine?

Fexofenadine is a second-generation antihistamine that selectively blocks H1 receptors, reducing allergic symptoms like sneezing, itching, and runny nose without significant sedation. This medication is widely used to manage allergic rhinitis and chronic urticaria, offering relief with minimal central nervous system effects.

Overview of Fexofenadine

Generic Name: Fexofenadine

Brand Name: Allegra, generics

Drug Group: Second-generation antihistamine (H1 receptor antagonist)

Commonly Used For

This medication is used to:

  • Treat seasonal allergic rhinitis (hay fever).
  • Manage chronic idiopathic urticaria (hives).
  • Relieve allergy-related symptoms.

Key Characteristics

Form: Oral tablets (30 mg, 60 mg, 120 mg, 180 mg), oral suspension (6 mg/mL), orally disintegrating tablets (detailed in Dosage section).

Mechanism: Competitively inhibits H1 histamine receptors, preventing allergic mediator release.

Approval: FDA-approved (1996 for Allegra) and EMA-approved for allergic conditions.

Allegra Allergy 180 mg fexofenadine hydrochloride tablets for 24-hour antihistamine relief
Allegra Allergy tablets contain 180 mg of fexofenadine HCl, providing 24-hour non-drowsy relief from sneezing, runny nose, and itchy or watery eyes.

Indications and Uses of Fexofenadine

Fexofenadine is indicated for allergic and dermatologic conditions, leveraging its antihistaminic properties to alleviate symptoms:

Seasonal Allergic Rhinitis (SAR): Treats symptoms like sneezing, nasal congestion, and itchy eyes caused by pollen, dust, or mold, effective within 1–2 hours, supported by allergy trials over 14 days.

Perennial Allergic Rhinitis (PAR): Manages year-round symptoms due to indoor allergens (e.g., pet dander, dust mites), improving quality of life, per ENT and allergy guidelines.

Chronic Idiopathic Urticaria (CIU): Controls hives and itching in CIU, reducing lesion frequency, with evidence from dermatology studies over 6 weeks.

Allergic Conjunctivitis: Used off-label to relieve itchy, watery eyes in allergic conjunctivitis, enhancing ocular comfort, supported by ophthalmologic research.

Atopic Dermatitis: Investigated off-label to reduce pruritus in mild atopic dermatitis, improving skin barrier function, with data from pediatric dermatology studies.

Food Allergy Symptoms: Explored off-label to mitigate mild allergic reactions (e.g., oral itching) from food allergens, under allergist supervision, with emerging evidence.

Exercise-Induced Anaphylaxis: Employed off-label to prevent symptoms in exercise-induced anaphylaxis, reducing histamine release, supported by sports medicine research.

Asthma with Allergic Triggers: Used off-label as an adjunct in allergic asthma to control rhinitis-asthma overlap, improving respiratory symptoms, with pulmonology data.

Contact Dermatitis: Investigated off-label for mild contact dermatitis relief, reducing itching and inflammation, with preliminary dermatologic findings.

Note: This drug is for symptomatic relief; consult a healthcare provider for persistent or severe allergies.

Dosage of Fexofenadine

Important Note: The dosage of this antihistamine must be prescribed by a healthcare provider. Dosing varies by age, condition, and formulation, with adjustments based on clinical evaluation.

Dosage for Adults

  • Seasonal Allergic Rhinitis or Chronic Idiopathic Urticaria: 60 mg twice daily or 120 mg once daily, or 180 mg once daily, taken with water.
  • With Renal Impairment: 60 mg once daily if CrCl <80 mL/min; monitor response.

Dosage for Children

2–11 years (Seasonal Allergic Rhinitis or CIU):

  • 2–11 years (weight 10.5–40 kg): 30 mg twice daily or 60 mg once daily (tablet/suspension).
  • 6–11 years: 30 mg twice daily (orally disintegrating tablet).
  • Under 2 years: Not recommended.

12 years and older: Adult dosing (60 mg twice daily or 180 mg once daily).

Dosage for Pregnant Women

Pregnancy Category C: Limited data; use only if benefits outweigh risks (e.g., severe allergies). Consult an obstetrician, with fetal monitoring.

Dosage Adjustments

Renal Impairment: Reduce to 60 mg once daily if CrCl <80 mL/min; avoid if <15 mL/min.

Hepatic Impairment: No adjustment needed; monitor in severe cases (Child-Pugh C).

Elderly: Start with 60 mg once daily; increase to 120 mg if tolerated.

Concomitant Medications: Avoid with antacids containing aluminum or magnesium (separate by 2 hours).

Additional Considerations

  • Take this active ingredient with water, avoiding fruit juices (e.g., grapefruit, orange) that reduce absorption.
  • Use a calibrated syringe for oral suspension in children.

How to Use Fexofenadine

Administration:

  • Swallow tablets or orally disintegrating tablets with water; let disintegrating tablets dissolve on the tongue without water if preferred.
  • Shake oral suspension well before use, measuring with a provided syringe or spoon.

Timing: Use once or twice daily, maintaining consistency (e.g., morning and evening).

Monitoring: Watch for drowsiness (rare), headache, or signs of allergic reaction (e.g., rash).

Additional Tips:

  • Store at 20–25°C (68–77°F), protecting from moisture and excessive heat.
  • Keep out of reach of children due to overdose risk.
  • Report severe dizziness, difficulty breathing, or signs of hypersensitivity immediately.

Contraindications for Fexofenadine

Hypersensitivity: Patients with a known allergy to Fexofenadine or other antihistamines.

Severe Renal Impairment: Contraindicated if CrCl <15 mL/min due to accumulation risk.

Concurrent Use with Certain Antacids: Avoid with aluminum/magnesium antacids due to reduced absorption.

Warnings & Precautions for Fexofenadine

General Warnings

Drowsiness: Minimal but possible; avoid driving if affected, especially in sensitive individuals.

Cardiovascular Effects: Rare QT prolongation; monitor in patients with heart conditions.

Renal Function: Risk of accumulation in severe impairment; adjust dose.

Hypersensitivity Reactions: Rare anaphylaxis or angioedema; discontinue if present.

Drug Interactions: Reduced efficacy with fruit juices; separate administration.

Additional Warnings

Hepatic Function: Monitor in severe impairment; no routine adjustment needed.

Elderly Sensitivity: Higher risk of side effects; start with lower doses.

Pediatric Use: Safety established for 2+ years; avoid under 2 years.

Photosensitivity: Rare skin reactions to sunlight; use protection.

Gastrointestinal Upset: Mild nausea or dyspepsia; take with food if needed.

Use in Specific Populations

Pregnancy: Category C; use only if essential with fetal monitoring.

Breastfeeding: Excreted in breast milk; monitor infant for effects.

Elderly: Higher risk of drowsiness; adjust dose if necessary.

Children: Limited to 2+ years; supervise closely.

Renal/Hepatic Impairment: Adjust dose; avoid in severe renal cases.

Additional Precautions

  • Inform your doctor about kidney disease, heart conditions, or medication history before starting this medication.
  • Avoid combining with other sedating drugs unless advised.

Overdose and Management of Fexofenadine

Overdose Symptoms

  • Drowsiness, dry mouth, or dizziness.
  • Severe cases: Tachycardia, hypotension, or seizures.
  • Headache, nausea, or restlessness as early signs.
  • Respiratory depression with extremely high doses.

Immediate Actions

Contact the Medical Team: Seek immediate medical help.

Supportive Care: Administer activated charcoal if ingested recently, monitor vital signs, and provide IV fluids.

Specific Treatment: Manage symptoms (e.g., benzodiazepines for seizures); no specific antidote.

Monitor: Check heart rate, blood pressure, and mental status for 24–48 hours.

Additional Notes

  • Overdose risk is low; store securely.
  • Report persistent symptoms (e.g., confusion, rapid heartbeat) promptly.

Side Effects of Fexofenadine

Common Side Effects

  • Headache (7–10%, relieved with rest)
  • Drowsiness (1–3%, minimal compared to first-generation antihistamines)
  • Nausea (2–5%, reduced with food)
  • Dizziness (1–4%, decreases with tolerance)
  • Upper Respiratory Infection (2–3%, transient)

These effects may subside with dose adjustment.

Serious Side Effects

Seek immediate medical attention for:

  • Cardiovascular: QT prolongation or palpitations.
  • Allergic: Anaphylaxis, angioedema, or severe rash.
  • Neurological: Seizures or severe drowsiness.
  • Gastrointestinal: Severe nausea or dyspepsia.
  • Respiratory: Difficulty breathing or wheezing.

Additional Notes

  • Regular monitoring for cardiac function in at-risk patients is advised.
  • Report any unusual symptoms (e.g., chest pain, swelling) immediately to a healthcare provider.

Drug Interactions with Fexofenadine

This active ingredient may interact with:

  • Antacids (Aluminum/Magnesium): Reduces absorption; separate by 2 hours.
  • Fruit Juices: Decreases bioavailability (e.g., grapefruit, orange); avoid concurrent use.
  • Erythromycin/Ketoconazole: Increases levels slightly; monitor if combined.
  • Rifampin: May reduce efficacy; adjust dose if needed.
  • Other Antihistamines: Enhances sedation risk; avoid combinations.

Action: Provide your healthcare provider with a complete list of medications.

Patient Education or Lifestyle

Medication Adherence: Take this antihistamine as prescribed to manage allergies, following the exact schedule.

Monitoring: Report drowsiness, rash, or difficulty breathing immediately.

Lifestyle: Avoid excessive sun exposure; wear sunglasses during allergy season.

Diet: Take with water; avoid fruit juices with doses; maintain hydration.

Emergency Awareness: Know signs of anaphylaxis or cardiac issues; seek care if present.

Follow-Up: Schedule regular check-ups every 3–6 months to monitor allergy control and kidney function.

Pharmacokinetics

Absorption: Well-absorbed orally (peak at 1–3 hours); reduced by food or fruit juices.

Distribution: Volume of distribution ~5.4–5.8 L/kg; 60–70% protein-bound.

Metabolism: Minimal hepatic metabolism; primarily excreted unchanged.

Excretion: Primarily renal (80%) as unchanged drug; biliary (10%); half-life 14.4 hours.

Half-Life: 14.4 hours, with sustained antihistaminic effect.

Pharmacodynamics of Fexofenadine

This drug exerts its effects by:

Selectively blocking H1 histamine receptors, reducing allergic inflammation.

Minimizing sedation by limited blood-brain barrier penetration.

Alleviating symptoms of rhinitis and urticaria with dose-dependent efficacy.

Exhibiting a favorable safety profile with rare cardiovascular risks.

Storage

Temperature: Store at 20–25°C (68–77°F); protect from moisture.

Protection: Keep in original container, away from light and humidity.

Safety: Store in a locked container out of reach of children due to overdose risk.

Disposal: Dispose of unused tablets per local regulations or consult a pharmacist.

Frequently Asked Questions (FAQs)

Q: What does Fexofenadine treat?

A: This medication treats allergic rhinitis and hives.

Q: Can this active ingredient cause drowsiness?

A: Yes, rarely; avoid driving if affected.

Q: Is Fexofenadine safe for children?

A: Yes, for 2+ years with a doctor’s guidance.

Q: How is this drug taken?

A: Orally as tablets or suspension, as directed.

Q: How long is Fexofenadine treatment?

A: As needed for allergy season or chronic hives.

Q: Can I use Fexofenadine if pregnant?

A: Yes, with caution; consult a doctor.

Regulatory Information for Fexofenadine

This medication is approved by:

U.S. Food and Drug Administration (FDA): Approved in 1996 (Allegra) for allergic rhinitis and urticaria.

European Medicines Agency (EMA): Approved for allergic conditions.

Other Agencies: Approved globally for allergy management; consult local guidelines.

References

  1. U.S. Food and Drug Administration (FDA). (2023). Allegra (Fexofenadine) Prescribing Information.
    • Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
  2. European Medicines Agency (EMA). (2023). Fexofenadine Summary of Product Characteristics.
    • EMA’s comprehensive information on the medication’s indications and precautions in Europe.
  3. National Institutes of Health (NIH). (2023). Fexofenadine: MedlinePlus Drug Information.
    • NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
  4. World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Fexofenadine.
    • WHO’s consideration of Fexofenadine for allergy relief.
  5. Journal of Allergy and Clinical Immunology. (2022). Fexofenadine in Allergic Rhinitis Management.
    • Peer-reviewed article on Fexofenadine efficacy (note: access may require a subscription).
Disclaimer: This article provides general information about Fexofenadine for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider, such as an allergist or primary care physician, before using this drug or making any medical decisions. Improper use of this active ingredient can lead to serious health risks, including inadequate symptom control or rare hypersensitivity reactions.
PV: 52
Previous ArticleHeart Valve Regurgitation
Next Article Heart Failure
Andrew Parker, MD
  • Website

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts

Valproate

November 13, 2025

Lithium

November 13, 2025

Guanfacine

November 7, 2025
Related Articles
V

Valproate

Comprehensive Guide to Valproate (Valproic Acid): Uses, Dosage, Side Effects, and More What is Valproate…

Lithium

L

Guanfacine

G

Lisdexamfetamine

L

Methylphenidate

M

Amphetamine

A
Search Drugs by Name
💊 Today’s Recommended Drug

Ferrous sulfate

F

Atorvastatin

A

Procarbazine

P

Jardiance

J

Phenobarbital

P

Irbesartan

I

Allopurinol

A

Ketamine

K

GoodMedToday is a global health blog providing trustworthy, reader-friendly information on diseases, medications, healthy living, and medical therapies. We help you make informed health decisions with content based on reputable medical sources.

Quick Links
Diseases & Conditions

Drugs & Medications

Symptoms

Healthy Living

Medical News

About Us
Legal & Support
Privacy Policy

Terms of Service

Medical Disclaimer

Advertising Policy

Editorial Policy
© 2025 GoodMedToday. All rights reserved.
  • Home
  • Health
  • News
  • Buy Now

Type above and press Enter to search. Press Esc to cancel.